There is a big push right now to increase production of COVID-19 vaccines for poor nations. However, this move was stalled at the World Trade Organization (WTO) last 11 March amid disagreement between richer and developing countries over the issue of patent rights.
South Africa and India planned to renew their bid at a two-day meeting to waive rules of the WTO's Trade-Related Aspects of Intellectual Property (TRIPS) agreement, a move that would allow generic or other manufacturers to make more vaccines.



















